Understanding Peritoneal Dialysis and Home Treatment Options

Home Dialysis Trends and Modality Prevalence in the United States

There has been a concerted push in recent years to expand the utilization of home dialysis across the United States. According to observations from the United States, the country has historically lagged behind other high-resource nations such as Canada, Sweden, Hong Kong, and the Netherlands in home dialysis adoption. In-center hemodialysis often presents a more demanding option for patients in terms of health-related quality of life, while home modalities can significantly lower the global cost of end-stage kidney disease care. Furthermore, staffing challenges and nurse shortages in clinical units have encouraged facilities to promote home peritoneal dialysis, where nurse-to-patient ratios can remain lower.

These converging pressures led the United States government to propose a target through the Advancing American Kidney Health executive order, aiming for 80% of kidney failure patients to receive home dialysis or transplantation. To support this initiative, the American Society of Nephrology established a Home Dialysis Task Force to broaden access. Data from the United States Renal Data System indicates that the incidence rate of patients starting peritoneal dialysis approximately doubled between 2010 and 2020. Even with that growth, losses to death, transplantation, and transfers to hemodialysis mean the overall prevalence moved only modestly from 7.9% to 11.7% of total dialysis patients over the decade.

Peritoneal Dialysis Mechanics and Treatment Schedules

Peritoneal dialysis utilizes the lining of a patient’s abdomen—known as the peritoneum—to filter blood internally. Several weeks prior to treatment initiation, a surgeon places a soft catheter into the abdomen. During an exchange, a dialysis solution containing water, salt, and other additives flows from a bag into the peritoneal cavity, where it absorbs wastes and excess fluid. After a designated dwell time, the used solution drains out into an empty bag.

• Continuous Ambulatory Peritoneal Dialysis (CAPD): Performed manually during the day without a machine, requiring solution changes at least four times daily with dwell times of four to six hours.
• Automated Peritoneal Dialysis (APD): Utilizes a machine called a cycler to automatically fill and empty the abdomen three to five times overnight while the patient sleeps.

Medical guidance emphasizes that planning catheter placement at least three weeks prior to the first exchange improves treatment success, allowing the exit site time to heal before a full schedule begins.

Predialysis Education and Modality Selection Outcomes

A central question in nephrology is what percentage of patients would choose home therapies if provided with unbiased education. International models demonstrate high penetration rates where home-first policies or robust education programs exist. For instance, Canada maintains 20% of its dialysis population on peritoneal dialysis and 5% on home hemodialysis, while the Netherlands records 16% and 4%, respectively. In contrast, the United States reports a substantially higher incidence rate of end-stage kidney disease, driven partly by an older, frailer patient demographic presenting with multiple comorbidities who may represent poor candidates for independent home care.

Targeted educational interventions can shift these trends. Data from a study conducted at Satellite WellBound clinics showed that when 986 patients with impending needs for kidney replacement therapy received intensive, comprehensive education regarding their choices, 36% ultimately initiated therapy using peritoneal dialysis.

Clinical Syndromes Associated with Atypical Mycobacterial Infections

Managing patients on chronic dialysis requires careful monitoring for concurrent complications, including atypical mycobacterial infections caused by species other than Mycobacterium tuberculosis and Mycobacterium leprae. These infections manifest across four clinical syndromes: pulmonary disease, lymphadenitis, skin and soft tissue disease, and disseminated disease. Pathogens such as Mycobacterium chelonae and Mycobacterium abscessus are distributed globally in water sources and can complicate surgical sites, trauma wounds, or other organ infections, particularly in individuals with underlying immune suppression.

Clinical features vary widely by species. While organisms like Mycobacterium avium-intracellulare primarily present with pulmonary symptoms or systemic illness in immunocompromised patients, skin-tropic variants can produce non-healing wounds, subcutaneous nodules, cellulitis, or localized abscesses.